Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034069 (
pulmonary fibrosis
)
7,050
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Chitotriosidase (
CHIT1
) is a highly conserved and regulated chitinase secreted by activated macrophages; it is a member of the 18-glycosylase family (GH18).
CHIT1
is the most prominent chitinase in humans, can cleave chitin and participates in the body's immune response and is associated with inflammation, infection, tissue damage and remodelling processes. Recently,
CHIT1
has been reported to be involved in the molecular pathogenesis of
pulmonary fibrosis
, bronchial asthma, COPD and pulmonary infections, shedding new light on the role of these proteins in lung pathophysiology. The potential roles of
CHIT1
in lung diseases are reviewed in this article.
...
PMID:Chitotriosidase: a marker and modulator of lung disease. 3235 87
Chitotriosidase (
CHIT1
) and acidic mammalian chitinase (AMCase) are the enzymatically active chitinases that have been implicated in the pathology of chronic lung diseases such as asthma and interstitial lung diseases (ILDs), including idiopathic pulmonary fibrosis (IPF) and sarcoidosis. The clinical and preclinical data suggest that pharmacological inhibition of
CHIT1
might represent a novel therapeutic approach in IPF. Structural modification of an advanced lead molecule
3
led to the identification of compound
9
(
OATD-01)
, a highly active
CHIT1
inhibitor with both an excellent PK profile in multiple species and selectivity against a panel of other off-targets.
OATD-01
given orally once daily in a range of doses between 30 and 100 mg/kg showed significant antifibrotic efficacy in an animal model of bleomycin-induced
pulmonary fibrosis
.
OATD-01
is the first-in-class
CHIT1
inhibitor, currently completed phase 1b of clinical trials, to be a potential treatment for IPF.
...
PMID:Discovery of
OATD-01
, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis. 3307 33